CClinicalTrials.gg
Active, not recruitingNCT07252167Updated Nov 26, 2025

Comparison Between Emdogain and Amniotic Membrane as a Scaffold in Endodontic Regeneration of Immature Anterior Teeth

An interventional study of Regenerative endodontic treatment with conventional blood clot technique. and regenerative endodontic treatment with emdogain. in Non-vital Immature Anterior Teeth, sponsored by Al-Azhar University. Active, not recruiting at 1 site in Egypt. Open to participants aged 7 Years to 12 Years. Per ClinicalTrials.gov, last updated 2025-11-26.

Sponsored by Al-Azhar University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2026, 7 months ago, but the record still lists the study as active, not recruiting.
  • Registered 8 months after the study started (first participant enrolled Mar 2025, registered Nov 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
39
Allocation
Randomized
Ages
7 Years to 12 Years
Sex
All
01

Study summary

To evaluate the clinical outcomes and cone-beam computed tomography findings of enamel matrix derivative and amniotic membrane in regenerative endodontic treatment of non-vital immature permanent anterior teeth

Read the detailed description

To evaluate the clinical outcomes and cone-beam computed tomography findings of enamel matrix derivative in comparison to amniotic membrane and MTA as a conventional group in regenerative endodontic treatment of non-vital immature permanent anterior teeth

02

Conditions studied

  • Non-vital Immature Anterior Teeth

Keywords

  • Revascularization, endodontic regeneration, Immature
03

In context

Lead sponsor

Al-Azhar University is the lead sponsor of 505 studies on the registry; 167 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

•Patients age ranges between 7 and 12 years at the time of enrolment including both genders. •Provision of informed consent by one parent or legal guardian. •At least one immature permanent anterior tooth diagnosed with pulp necrosis with or without periapical lesions. •Restorable teeth. •Compliant patient/parent. •Radiologic evidence of open apices (Teeth are considered immature when a minimum of 1 mm apical foramen width is evident)

Exclusion criteria

Exclusion Criteria:

•Teeth with root fractures or split roots. •Presence of root resorptions. •Presence of periodontal pockets. •Developmental anomalies. •Presence of periapical radiolucency of more than 10 mm. •Tooth with class III mobility.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
39 participants (actual)

Study arms

  • Experimental
    Regenerative endodontic treatment using MTA

    Regenerative endodontic treatment with conventional blood clot technique.

    Other: Regenerative endodontic treatment with conventional blood clot technique.

  • Experimental
    Regenerative endodontic treatment using emdogain

    regenerative endodontic treatment with emdogain

    Other: regenerative endodontic treatment with emdogain.

  • Other
    Regenerative endodontic treatment using amniotic membrane

    regenerative endodontic treatment with amniotic membrane

    Other: regenerative endodontic treatment with amniotic membrane

Interventions

  • OtherRegenerative endodontic treatment with conventional blood clot technique.

    After local anesthesia, rubber dam isolation and access cavity preparation, pulp tissue extirpation/debridement, the root canal system is minimally instrumented. Copious irrigation is performed, gently with single-side vented needles. Canals are dried with paper points. Metapaste is injected as intracanal medication. At second session, check for absence of signs/symptoms. Copious gentle irrigation and drying of canals with paper points is done. Bleeding is created in root canal by over-instrumentation until bleeding is evident in the cervical portion of the canal. A lightly moistened sterile cotton pellet is placed into the canal, 3-4 mm apical to the CEJ, for 7-10 minutes to allow blood clot formation. Placement of MTA over the blood clot as a capping material. A 3-4 mm layer of glass ionomer is gently placed over the capping material. Followed by resin composite restoration.

  • Otherregenerative endodontic treatment with emdogain.

    • After local anesthesia, rubber dam isolation and access cavity preparation, pulp tissue extirpation/debridement, the root canal system is minimally instrumented. Copious irrigation is performed, gently with single-side vented needles. Canals are dried with paper points. Metapaste is injected as intracanal medication. At second session, check for absence of signs/symptoms. Copious gentle irrigation and drying of canals with paper points is done. Bleeding is created in root canal by over-instrumentation until bleeding is evident in the cervical portion of the canal. A lightly moistened sterile cotton pellet is placed into the canal, 3-4 mm apical to the CEJ, for 7-10 minutes to allow blood clot formation. Emdogain is injected inside the canal on the blood clot up to the CEJ to act as a matrix for the cells. Placement of MTA over the blood clot as a capping material. A 3-4 mm layer of glass ionomer is gently placed over the capping material. Followed by resin composite restoration.

  • Otherregenerative endodontic treatment with amniotic membrane

    \- After local anesthesia, rubber dam isolation and access cavity preparation, pulp tissue extirpation/debridement, the root canal system is minimally instrumented. Copious irrigation is performed, gently with single-side vented needles. Canals are dried with paper points. Metapaste is injected as intracanal medication. At second session, check for absence of signs/symptoms. Copious gentle irrigation and drying of canals with paper points is done. Bleeding is created in root canal by over-instrumentation until bleeding is evident in the cervical portion of the canal. A lightly moistened sterile cotton pellet is placed into the canal, 3-4 mm apical to the CEJ, for 7-10 minutes to allow blood clot formation. Amniotic membrane will adapted inside the canal on the blood clot up to the CEJ. Placement of MTA over the blood clot as a capping material. A 3-4 mm layer of glass ionomer is gently placed over the capping material. Followed by resin composite restoration.

06

What researchers measure

Primary outcomes

  1. Radiographic assessment of root length by CBCT

    For all cases, CBCT was taken at a setting of 3-7 mA and 120 kVp and an exposure time of 9 s. Each scan was taken over 360º with a 0.3 mm voxel size. The root length was measured using the CBCT ruler to draw a line from the center point of the line connecting CEJ to the most apical point in the center of the root apex (proximally and facially). The percentage of increase in root length was calculated using this formula: (12 months value - preoperative value )/Preoperative value X 100%

    Time frame: Baseline (immediately post-operative), an 12 months post-operative.

  2. Radiographic assessment of diameter of apical foramen by CBCT

    Diameter of the apical foramen was measured using the CBCT ruler at the most apical points buccolingually at the sagittal (proximal) view of CBCT. It was also measured at the most apical points mesiodistally at the coronal (facial) view of CBCT. The percentage reduction of the apical diameter was calculated using this formula: ( preoperative value - 12-month value ) /Preoperative value \*100%

    Time frame: Baseline(immediately post-operative), and 12 months post-operative.

  3. Radiographic assessment of root area by CBCT

    Radiographic root area (RRA) was measured using a method described by Flake et al using the polygon selection tool of CBCT. Below a straight line marking the CEJ, the root area was outlined from the surrounding periodontal environment. Then, the pulp space area was measured by the same method using the polygon tool by tracing the reference points surrounding the pulp space. Finally, RRA was calculated by subtraction of the pulp space area from the outer root area. These measurements were made at proximal and facial views of CBCT . The percentage increase in RRA was calculated using this formula: ( 12-month value - preoperative value )/Preoperative value X 100 %

    Time frame: Baseline (immediately post-operative), and 12 months post-operative.

  4. Radiographic assessment of size of periapical lesion by CBCT

    Lesion size was measured by tracing the periphery of the lesion using the polygon tool of the CBCT from proximal and facial views of the CBCT. A closed polygon tool was used to delimit the border of the lesion to measure the area of the periapical lesion in (mm2).The percentage reduction of lesion size was calculated as follows: ( preoperative value - 12-month value ) /Preoperative value X 100 %

    Time frame: Baseline (Immediately post-operative), and 12 months post-operative.

Secondary outcomes

  1. Clinical assessment of presence/ absence of pain

    Assessment of symptoms of patient whether there is a pain or not in each follow up period.

    Time frame: Baseline, 3 months, 6 months, and 12 months post operative.

  2. Clinical assessment of presence/ absence of mobility of teeth

    Assessment of teeth whether they exhibit mobility or not

    Time frame: Baseline, 3 months, 6 months, and 12 months post operative.

  3. Clinical assessment of presence/ absence of associated sinus tract or swelling.

    Assessment of teeth whether they exhibit associated sinus tract or swelling or not

    Time frame: Baseline, 3 months, 6 months, and 12 months post operative.

  4. Clinical assessment of presence/ absence of tenderness to palpation of adjacent soft tissues.

    Assessment of teeth whether they exhibit tenderness to palpation of adjacent soft tissues or not

    Time frame: Baseline, 3 months, 6 months, and 12 months post operative.

  5. Clinical assessment of presence/ absence of tenderness to percussion

    Assessment of teeth whether they exhibit tenderness to percussion

    Time frame: Baseline, 3 months, 6 months, and 12 months post operative.

07

Study locations

1 site
  • Al Azhar university
    Cairo, Egypt
08

References and documents

Individual participant data

Plan to share: Yes

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 26, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07252167
Lead sponsor
Al-Azhar University
Responsible party
Abrar Hamed Habib Yousef (Assistant Lecturer, Al-Azhar University) — Principal investigator
First posted
Nov 26, 2025
Start date
Mar 1, 2025
Primary completion
Mar 1, 2026 (estimated)
Completion
Apr 1, 2026 (estimated)
Last update
Nov 26, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion